Nucleoside analogs with carboxamidine modified monocyclic base
US7638496B2 · kind B2 · utility
0Cited by
25References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2002 |
| Grant date | Dec 29, 2009 |
| Priority date | — |
| Expiry date | Dec 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel nucleoside analog compounds are disclosed. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 and Type 2 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.